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SUMMARY – A well balanced, time-restricted diet with 50% more vegetables and restriction of 
red meat can delay the progression of kidney damage. This paper suggests that such diet changes can 
also have an immunoregulatory role, with adding pre/probiotics. There were two groups of patients 
(20M/28F; age 67±9 years, estimated glomerular filtration rate 42,1±12 ml/min/1.73m2): group A 
practiced a modified diet that consisted of certain nutritional changes (50% more vegetable intake, 
reduction of red meat to twice per week), time-restricted eating (8 hours), and taking probiotics. 
Group B was also taking probiotics; however, their nutrition included no restrictions on red meat in-
take, they ate fewer vegetables, and there was no time-restricted eating.
After 3 months, therapy from Group A − a balanced, time-restricted diet plus probiotics, resulted 
in weight loss (from 113±13 to 110±18 kg), body mass index decrease (from 36.4±5.1 to 34±5 kg/m2), 
decrease in waist circumference (from 119±11 to 115±10 cm), as well as lower hsC-reactive protein by 
8% (group A) and 5% (group B). The values of kidney function measurements after 3 months were 
45,3±11 ml/min/1.73m² in group A, while in group B, those were 42,4±10 ml/min/1.73m² (p<0.05). 
This study shows a positive correlation between the daily consumption of probiotics and decreased 
progression of chronic kidney disease.
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Introduction
An imbalance of intestinal microflora and the de-
struction of the intestinal barrier function can enhance 
the occurrence and progression of chronic kidney 
damage. Chronic kidney disease (CKD) related dys-
biosis and changes in the intestinal barrier lead to in-
flammation with an increased translocation of living 
bacteria products from the intestinal lumen into the 
circulation1. In CKD, dysbiotic intestinal microflora 
has been reported with an increase in pathogenic com-
pared to symbiotic flora1,2. The intestinal microflora 
produces indoles, phenols, and amines, that are ab-
sorbed and accumulated in CKD patients, with harm-
ful effects. These gut-derived uraemic toxins and the 
increased permeability of the intestinal barrier in CKD 
patients cause increased inflammation and oxidative 
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stress, cardiovascular disease, anaemia, mineral metab-
olism disorders, and CKD progression2. The interac-
tion between the intestinal microbiota and the kidney 
is known as the ‘gut–kidney axis’3. The high concentra-
tion of ammonia results in lower pH in the gastroin-
testinal tract, prolonged colonic transit, and dietary 
restrictions leading to decreased fibre intake 4. The 
pathophysiology of chronic inflammation in CKD is 
the consequence of many factors such as cellular − oxi-
dative stress, tissue − hypoxia, microbial factors − gut 
dysbiosis, and retention of uraemic toxins (glycation 
end products, calcioprotein, indoxyl sulphate) 3. The in-
take of prebiotics and probiotics could lead to an im-
provement of the dysbiosis and/or an increase of per-
meability of the intestinal barrier in many conditions 
and diseases5.
As stated, by adding 50% more vegetables to the 
diet and reducing red meat intake, and with 8-hour 
fasting, the progression of chronic kidney disease and 
damage in a terminal stage can be delayed6. We also 
suggest a potential immunoregulatory role of diet 
changes and adding pre/probiotics (inulin/bifidobac-
teria and lactobacilli) in CKD patients with estimated 
glomerular filtration rate (eGFR) >30 ml/min/1.73m2.
Subjects, materials, and methods
This study included 48 non-dialysis CKD patients 
(20M/28F; average age 67±9 years, average eGFR 
42,1±12 ml/min/1.73m2.) with no medical history of 
any gastrointestinal inflammation disease, disorders of 
liver function, or diabetes. Exclusion criteria were 
therapy with potassium and phosphate binders, antibi-
otics, oral iron, oral anticoagulation therapy (OACs) 
and proton pump inhibitors; conditions like CKD 
stage 4 and 5, kidney transplantation, heart failure, 
anemia, malnutrition or inflammation (measured with 
C-reactive protein or hs CRP>5mg/l). There were two 
groups of patients: group A had a modified diet that 
consisted of certain nutritional changes (50% more 
vegetable intake, reduction of red meat intake to twice 
per week), time-restricted eating (8 hours), and taking 
probiotics (inulin/bifidobacteria and lactobacilli twice 
daily). Group B was also taking probiotics, but their 
nutrition included no restrictions on red meat intake, 
they ate fewer vegetables, and there was no time-re-
stricted eating. A food frequency survey was used to 
collect information on food consumption at home, as 
well as the number of servings (<3, >3), like in previous 
study 6. There were no differences in kidney function, 
cholesterol, serum albumin, age, sex, fasting glucose, 
duration, and hypertension therapy between groups 
and constipation. Constipation was defined as a diges-
tive system condition where an individual has hard 
feces difficult to expel (Y or N) 7. We also evaluated the 
hyperkalaemia risk of increased intake of fruits and 
vegetables and measured hsC-reactive protein (CRP) 
before and after 3 months of stated therapy to manip-
ulate the microbiota with probiotics.
Patients were taking antihypertensive medications, 
including angiotensin II receptor blockers or ACE in-
hibitors, calcium blockers, and diuretics. Their blood 
pressure was measured twice in the sitting position 
(with a conical cuff that fits normal and large arms) 
after a resting period of 10 minutes. Serum creatinine 
levels data, as well as age, sex, and race were used to 
calculate the estimated GFR using the Chronic Kidney 
Disease Epidemiology Collaboration (CKD-EPI) for-
mula8. The protocol of this study follows the Declara-
tion of Helsinki, as well as local institutional guidelines, 
and it was approved by the local ethics committees.
Data are expressed as means ± SD for normally 
distributed values, as median with range for non-nor-
mally distributed values, and percentage. The level of 
statistical significance was chosen to α=0.05. Statistical 
analysis was performed by statistical package SPSS, 
version 17.0 for Windows.
Results
Table 1. shows the study subjects’ characteristics. 
Our primary goal was to evaluate the efficacy and safe-
ty of reduced intake of red meat (twice per week), in-
creased vegetable intake (50% more), plus probiotics, 
and a time-restricted diet (min. 8-hour fasting) in 48 
CKD patients with eGFR>30ml/min/1.73m2. There 
were no statistically significant differences between 
laboratory values in groups of patients stratified ac-
cording to the primary kidney disease, age, and sex. 
HsC-reactive protein was measured before and after 3 
months of therapy to manipulate the microbiota with 
probiotics and diet. In group A, the treatment that in-
cluded diet changes plus probiotics after 3 months re-
sulted in body mass index decrease (BMI) from 
36.4±5.1 to 34±5 kg/m2, weight loss from 113±13 to 
110±18 kg, and in a decrease of waist circumference 
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from 119±11 to 115±10 cm. Kidney function mea-
sured with eGFR after 3 months in group A increased 
to 45,3±11 ml/min/1.73m², while in group B, it was 
42,4±10 ml/min/1.73m²(p<0.05). Furthermore, in 
group A the 3-month administration of diet plus pro-
biotics caused decrease in systolic BP (SBP from 
145±15 to 140±12 mmHg (p<0.05). On the other side, 
their diastolic BP (DBP from 82±19 to 78±16 mmHg 
(p=0.9)) and heart rate (HR from 78±10 to 75±11 
beats/min (p=0.01)) did not significantly change.
Group B showed no changes in BMI (from 
36.4±5.1 to 36.4±4.5), waist circumference (from 
119±11 to 118±13 cm), nor in eGFR (from 42,1±12 
ml/min/1.73m2 to 42.4±10 ml/min/1.73m2, p=0.01). 
Also, during this 3-months study period, there was no 
significant decrease in BP (SBP from 145±15 to 
144±11 mmHg, DBP from 82±19 to 81±6 mmHg 
(p=0.01)) and HR (from 79±10 to 76±10 beats/min 
(p=0.9)). HsC-reactive protein value decreased in both 
groups − 8% in group A and 5% in group B. The food 
frequency survey with data on food consumption at 
home and the number of servings consumed has 
shown that 84% of patients in group A have >3 con-
sumption/day, while in group B, there were 65% of pa-
tients with less than <3 consumption/day. In group B, 
the mean eGFR after 3 months was lower than in 
group A, and it was statistically significant (p<0.05). 
During this study, the patients did not incur any ad-
verse event like hyper- or hypotensive episode, acido-
sis, or potassium>5.1 mmol/L. At the end of the study, 
only 13% of patients in group A had problems with 
constipation (answer Y), while the great majority (an-
swer N) of 87% had no constipation problems. On the 
other hand, 70% of patients in group B had problems 
with constipation (p<0.05).
A clinical follow-up after 3 months was performed. 
No one from group A patients has had a worsening 
of kidney function after the end of the study, and 50% 
of them were still following a similar diet with less 
red meat, more vegetables and high-fiber foods and 
probiotics.
Discussion
There has been significant progress in the preven-
tion, detection, and treatment of CKD, but the fact is 
that it still remains a significant public health prob-
lem2. Therefore, it is necessary to develop new ap-
proaches to treat CKD patients 6,7. New evidence has 
shown that the intestinal microbiota can affect arterial 
blood pressure and hypertension may therefore be an-
other gut dysbiosis mediated cause of kidney disease9. 
This study showed that BP control is better in both 
groups by adding probiotics to the daily diet. Also, re-
ducing red meat intake to 2x weekly and increased in-
take of vegetables (50% more), with time-restricted 
feeding (8-hour fasting), can slow down and delay the 
chronic kidney disease progression and could clearly 
benefit the CKD patients6. Our results in this new 
study support these previous observations and indicate 
that probiotics and high fiber-rich diets have addition-
al anti-inflammatory properties and can decline CKD 
progression10. Some medications (potassium and 
phosphate binders, proton pump inhibitors, oral iron, 
and antibiotics) may underlie a changed composition 
of the intestinal microbiota in uraemic patients11. So 
patients taking such medications were excluded from 
the study. The daily diet is crucial and different poly-
phenols, such as anthocyanin, catechin, chlorogenic 
acid, and resveratrol, can regulate intestinal microor-
ganisms, inhibit pathogenic bacteria, and improve 
inflammation in CKD patients12.
The present study includes potential limitations. 
First, there was a small number of participants. Sec-
ond, microbiota, phosphate load, and oxidative stress 
were not measured. Third, our evaluations were based 
on measuring the serum creatinine, eGFR and hsCRP 
Table 1.: Patients characteristics (clinical and metabolic)
Gender 20/28 (M/F)
Age 67 (58-76)
CKD (duration in years) 9 (7-12)
BMI (kg/m2) 36.4 ±5.1
SBP (mmHg) 145 (130-160)
DBP (mmHg) 82 (63-101)
hs CRP (mg/L) 3.4±1.5
Serum albumine (g/L) 38.1±2.3
Fasting glucose (mmol/L) 5.4±1.2
Total cholesterol (mmol/L) 5.4 (3.6-6.8)
Potassium (mmol/L) 4.4±0.5
Creatinine (umol/L) 152 (138-175)
eGFR (ml/min/1.73m2) 42.1 (31-55)
BMI – index of body mass; SBP/DBP − systolic/diastolic blood 
pressure; hs CRP − high sensitive C reactive protein; eGFR − esti-
mated glomerular filtration rate
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on two consecutive periods before and after 3 months, 
so it may not reflect the relation over time.
To conclude, the results of this study suggest a pos-
itive correlation between daily probiotics consumption 
and decreased progression of CKD (in both groups). 
Therapies that include a high fiber diet and probiotics 
may enhance the well-being of CKD by attenuating 
uremia-induced alteration of the gut microbiome. The 
plant-based nutrition with additional pre/probiotics 
consumption should be implemented as a new ap-
proach to CKD patients and included as a clinical rec-
ommendation for their treatment.
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Sažetak
PROBIOTICI I DIJETALNA PREHRANA BOGATA VLAKNIMA  
UZ PROTUUPALNE UČINKE USPORAVA I PROGRESIJU KRONIČNE BUBREŽNE BOLESTI
I. Prkačin, P. Fidri, A. Marija Novak, J. Pleše, T. Bulum i I. Bubić
Istražili smo učinak dodatka probiotika i njegovu potencijalnu imunoregulatornu ulogu u 48 bolesnika s kroničnom 
 bubrežnom bolesti kroz 3 mjeseca. U prospektivnoj studiji (20M/28F; srednje dobi 67±9 godina, eGFR 42,1±12 mlmin-
11.73m2.) bolesnici su bili podijeljeni u skupinu A s dijetom koja je uključivala smanjeno uzimanje crvenog mesa (samo 2x 
tjedno), povećan unos povrća na 50%, uz 8-satni vremenski period bez uzimanja hrane i uz dodatak probiotika. Skupina B 
nije mijenjala postojeće prehrambene navike, međutim uzimala je isti probiotik kao i skupina A. U periodu praćenja nakon 
3 mjeseca postignuta je značajno sniženje tlaka, težine i opsega struka u grupi A: BMI s 36.4±5.1 na 34±5 kg/m2, tjelesna 
težina s 113±13 na 110±18 kg, opseg struka s 119±11 na 115±10 cm, dok u skupini B nisu zabilježene promjene. U obje 
grupe uočeno je sniženje razine hsCRP-a, i to za 8% u grupi A, odnosno 5% u grupi B.
Bubrežna funkcija procijenjena eGFR nakon 3 mjeseca u skupini A iznosila je 45.3±11 ml/min/1.73m², a u grupi B 
42.4±10 ml/min/1.73m² (p<0.05). Prehrana sa sniženim unosom proteina životinjskog porijekla, više proteina biljnog pori-
jekla, pridržavanje neuzimanja hrane kroz osam sati i dodatak probiotika, dodatno usporava progresiju kronične bubrežne 
bolesti i ima protuupalni učinak.
Ključne riječi: probiotici, dijetalna prehrana bogata vlaknima, kronična bubrežna bolest
